Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Major Shareholder Orbimed Advisors Llc Sells 281,408 Shares

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) major shareholder Orbimed Advisors Llc sold 281,408 shares of the stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $45.02, for a total transaction of $12,668,988.16. Following the completion of the transaction, the insider owned 245,728 shares in the company, valued at $11,062,674.56. The trade was a 53.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Bitwise MARA Option Income Strategy ETF Trading Down 1.9%

IMRA opened at $17.02 on Thursday. Bitwise MARA Option Income Strategy ETF has a 1-year low of $11.99 and a 1-year high of $54.94. The company has a market capitalization of $3.23 million, a PE ratio of 340.40 and a beta of 2.88. The firm’s 50 day simple moving average is $16.35 and its two-hundred day simple moving average is $15.83.

Bitwise MARA Option Income Strategy ETF Company Profile

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.